Growth
$KLSE-INFOTEC FYE2023 Number of workforce (Employees)INDEX:KLSE -INFOTEC
Number of workforce (Employees):
26 permanent + 5 contract
= 31 employees in total
(dated LPD 23 May 2022, reported in IPO Prospectus dated 20 June 2022, page 132)
60 employees in total
(dated 31 May 2023, reported in NST News).
The number of employees have been doubled in a year, indicating rapid and aggressive APAC regional expansions have taken place.
Important point emphasized in the NST news: The team is still growing in line with its expansion drive.
That would translate into that more employees are expected onboard driven by continual business growth and in turn additional employees will push growth further on.
$KLSE-INFOTEC FYE 2023 Segments' GPM StudiesINDEX:KLSE -INFOTEC
FYE 2023 Segments' GPM Studies:
IT Infrastructure Solutions Segment GPM
= (19,142÷43,551)×(43,145÷43,551)
= 43.54%
Cybersecurity Solutions Segment GPM
= (990÷2,994)×(2,990÷2,994)
= 33.02%
Managed IT Services and Other IT
Services Segment GPM (Recurring)
= (16,686÷22,378)×(20,563÷22,378)
= 68.52%
Trading of Ancillary Hardware and Software Segment GPM
= (935÷5,374)×(5,231÷5,374)
= 16.94%
Pretty Impressive!
Can ROKU run before earnings? LONGROKU on a daily chart is sitting on support in consolidation since the trend down after the
last earnings report. In three weeks there will be another report. The prior report showed
negative earnings but it did beat the estimates while revenues were a mild surprise. I expect
ROKU has done some belt trimming to try to get expenses decreased while growing revenues.
My long trade here is from thin support but targets the Fibonacci level of a retracement
back to recent high pivots. The target is 80 representing 30% upside. A stop loss will be
initially set at 61 but then raised 3.5% every time price rises 3% to gradually tighten it.
I will take a good part of the hopeful profits off the table a few days before the upcoming
report.
Navigating Market Waters: Embracing Flexibility on US30In trading, adaptability is key. Reflect on the journey navigating the volatile waves of US30. While some trades may slip away, embracing the fluidity of the market ensures resilience and growth. Let's explore the importance of flexibility and seizing opportunities amidst market turbulence.
Infoline Tec Group @KLSE: Revenue FYE 2024Forecast by APEX SECINFOTEC@KLSE
Apex Securities
academy.apexetrade.com/filestore/research-pdf/20240226_Infotec_4QFY23_Results.pdf
Revenue FYE 2024Forecast by Apex Securities
= 120.5M
Assuming the Net Profit Margin remains at 26.8%:
Net Profit FYE 2024 Forecast
= 120.5×0.268
= 32.294M
$KLSE-INFOTEC: EV/EBIT ÷ EBIT Growth MultipleINDEX:KLSE -INFOTEC
EV/EBIT ÷ EBIT Growth Multiple
EV@RM0.805
= 0.805×363,229+389+119+407+107-10,780-8,445
= 274,196.345
EBIT
= 25,792+38
= 25,830
EV/EBIT
= 274,196.345÷25,830
= 10.6154217964
EBIT Growth
= 100×(25,830÷16,683-1)
= 54.8282682971%
EV/EBIT ÷ EBIT Growth Multiple
= 10.6154217964÷54.8282682971
= 0.1936122027 Extremely Low, Extremely Undervalued
MCD is topped out the long fast food trend may be SHORTMCD lives on people liking what they eat and eating a lot of it. The Happy Meal is famous.
into the business model comes the new wave biologics for obesity and diabetes. the shots
that cut down the weight and the food addiction. Insurance companies are jumping on
the bandwagon. 1/3 of the people eat half the food. Increasingly, those people are seeking
treatment. The fastfood executives know this. Same for the sugar beverages.
Anyway, enough said. MC on the monthly chart is stuck at a double top even more obvious
on a weekly or daily chart. At present it is stuck in a symmetrical triangle compressing price.
The mathematical predictive algorithm forecasts price will move down the remainder of
this year. I respect the mathematics and understand the medical trend. LLY makes money
supplying insulin and now it makes money actually reversing diabetes and obesity. One way
or another it makes money and MCD is supplying the patient flow. In the meanwhile if
those patients are detoxified and lower their caloric intake, MCD is the one that suffers
a regression of the growth story. I am short MCD and add to my position whenever
there is a little upward price movement. Yeah, comarketing donuts with Krispy is an act of
desperation.
SWIMMING with the WHALES, a dangerous move, NEXT TARGET $Whales waited, Retail traders PLUNGED, then WHALES SOLD. Know your game. Dont get maneuvered into the FEARLESS CROUD.
Whales red downtrend regression. Showing a deep analysis behind the scenes of BITCOIN. Shows who’s in, who’s out within the time as the white trend moves. Follow each zigzag and know how it all started.
Next target is kept secret: this helps keep smart money intruders from changing directions.
$HTOO: Potential Bullish Reversal - Solid News & Webcast Ticker NASDAQ:HTOO - Fusion Fuel Green PLC
We could be looking at a nice test and cross of the Ichimoku Cloud, here represented on a 1 Month chart. This price movement is also accompanied with news regarding the selection and acceptance of a 650M$ project funded by the EU, which Fusion Fuel proposed in regards to the hydrogen transition, please read in more detail below in the press release of Feb.16 2024.
There is also a Webcast for investors on March 6th, which could lead to some updates on positive revenue forecast and more details over the 650M$ project and next steps.
This company is currently valued at around 32M$, which could be undervalued if this project goes forward, IMO.
I'll be sitting long in the short to mid-term and might sell for profits at some critical levels.
Happy trading.
AVTX - a potential continuation WATCHAVTX popped on a big revenue beat on March 28th. It is now priced at about 3% of the ATH
of last July. With the massive price jump came a 15X relative volume. The question is
whether price has retraced into support and can rally again in the next market session.
This remains to be seen. i will put AVTX on the top of my watch list and take a long trade
if I see signs of continuation with volume supporting the move.
INFOLINE TEC GROUP@KLSE : OCROICₘₒ𝒹 based ValuationINFOLINE TEC GROUP@KLSE
OCROICₘₒ𝒹 based Valuation
OCROICₘₒ𝒹
= 100×(6,325+(7,419+29,115+2,105)-(1,836+6,312+3,312+5,216))÷(58,317+4,879+407+107+(7,419+29,115+2,105)-(1,836+6,312+3,312+5,216))
= 33.0185706115
OCPS
= (6,325+(7,419+29,115+2,105)-(1,836+6,312+3,312+5,216))÷363,229
= RM 0.0778792442
OCROICₘₒ𝒹 based Intrinsic Value (min) with 3.5% inflation rate
= RM 0.0778792442×(1-(1÷1.035)^33.0185706115)÷(1-(1÷1.035))
= RM 1.5634207107
OCROICₘₒ𝒹 based Intrinsic Value (max)
= RM 33.0185706115×0.0778792442
= RM 2.5714613246
EL jumps on analyst upgrade LONGEL like ULTA was beaten down in covid times. It jumped in 2021 and fell in 2022 and 2023.
2024 might be the year they thrive again. On the weekly chart, EL is back to the support of
its levels of 2018. With an analyst upgrade coming from Bank of America it is now getting a
bit of attention. Trend strength and relative strength were down. I see this as a good entry
for a new long position in EL while also looking at ULTA. Targets are the fib zone and a
correction / consolidation area on the downtrend so 200 and 250. Now is the time to invest
in female beauty.....
CMG to split price SHORTCMG has announced a split. Makes sense to make shares more affordable but fractionals are
widely available. CMG may be fundamentally challenged by the underpinnings of the fast food
markets. that is overeating and rising prices. In the meanwhile the anti-obesity and anti-
diabetes trends are pushing hard led by the bological injectable meds from LLY, NVO and
others. One third of the people eat one half of the food and now an effective treatment
for that addiction is becoming increasingly available. The writing is on the wall and food biz
executives can read that writing. Enough said.
I am going short on CMG. It's best days of growth may behind it. The company announced plans
for 4000 more stores nationwide. Really? Time will tell. I vote with my wallet. My position
will not be small. The predictive algo has its forecast. My education included both medicine
and engineering. I understand the power of biology and mathematics. I deeply respect
both.
AAPL on a wide view continues SHORTAAPL on the weekly continues to fall from a double top put in at 195 in July 23 and this past
January. China issues are looming with competition domestically within China, factory issues
and the recession. The hart shows an established trend down seeking support at the Fibonacci
level in blue. The predictive algo looking back an the regression line pattern forecasts a
continued fall through the fib zone into the 125 area. Indicators are all consistent with the
same. I have a deep respect for advanced mathematics and will comply with the forecast.
AAPL is a short and the little retrace up is an opportunity to add to my positions.
LITM a lithium penny stock gets momentum LONGLITM is a lithium mining company with operations is Western USA and Canada now getting a
lift as lithium prices are rising. It popped 16% today and hit a screener on volume yesterday.
This is a junior miner compared with LAC and SGML. As such it is more reactive to price. All
indicators confirm the move including the extent of the trend, relative volume spiking and the
RS lines. This is a low float low volume stock.
Accumulation of a low float could precipitate more price action upward quite easily.
As a volatile penny stock LITM is risky. Right now, I see a long trade in a
small position ( < 0.001 of account balance) for the potential gain despite the obvious risk
SL at 10% Targets at 10% 20% (red line pivots to the left-1.2o December to Feb) then 70% (
pivot low March 23) and finally 250% for the runners ( January and July 23 high pivots). Time
will tell. I expect great profit in this swing trade with stratified partial profits and less time
effort in the trend using alerts and notifications. A trailing loss will be employed at 10%
once the trade is over 20% profit.